$IONQ Cashflow Statement | Understand Stock

$IONQ

$32.80 +$2.04 (6.63%) Live

$IONQ Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Non-cash research and development arrangements
Amortization of customer warrant
Stock-based compensation
(Gain) loss on change in fair value of warrant liabilities
Offering costs associated with warrants
Deferred income taxes
Amortization of premiums and accretion of discounts on available-for-sale securities
Other, net

Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current assets
Other noncurrent assets
Accounts payable
Accrued expenses and other current liabilities
Operating lease liabilities
Unearned revenue
Other assets and liabilities

Net cash provided by (used in) operating activities
Cash flows from investing activities:
Purchases of property and equipment
Capitalized software development costs
Intangible asset acquisition costs
Purchases of available-for-sale securities
Maturities of available-for-sale securities
Purchases of privately-held securities
Businesses acquired, net of cash paid and acquired
Other investing, net
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Proceeds from Issuance of Common Stock
Proceeds from stock options exercised
Proceeds from warrants exercised
Other financing, net
Tax withholding receipts related to vested and released restricted stock units
Tax withholding payments related to vested and released restricted stock units
Proceeds from public warrants exercised
Repurchase of early exercised stock options
Proceeds from merger and PIPE transactions, net of transaction costs
Net cash provided by (used in) financing activities

Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash
Net change in cash, cash equivalents and restricted cash
Cash and cash equivalents at the beginning of the period
Cash and cash equivalents at the end of the period
Cash, cash equivalents and restricted cash at the beginning of the period
Cash, cash equivalents and restricted cash at the end of the period
Supplemental disclosures of non-cash investing and financing transactions
Issuance of common stock for intellectual property
Issuance of common stock for research and development arrangement
Property and equipment purchases in accounts payable and accrued expenses
Intangible asset purchases in accounts payable and accrued expenses
Vesting of customer warrants
Operating lease right-of-use assets subject to lease liability
Remeasurement of operating lease right-of-use assets due to lease modification
Noncash reclassification of warrant liabilities to equity upon exercise
Bonus settled in restricted stock units
Equity issued for acquisitions
Equity issued for intangible assets
Equity issued for research and development arrangement
Net share settled stock option exercises

Comments